Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 278

1.

Impact of Age on Risk of Lymph Node Positivity in Patients with Colon Cancer.

Wang H, Lu H, Yang H, Zhang X, Thompson EW, Roberts MS, Hu Z, Liang X, Li X.

J Cancer. 2019 May 12;10(9):2102-2108. doi: 10.7150/jca.28377. eCollection 2019.

2.

Human-specific RNA analysis shows uncoupled epithelial-mesenchymal plasticity in circulating and disseminated tumour cells from human breast cancer xenografts.

Tachtsidis A, Le AV, Blick T, Gunasinghe D, De Sousa E, Waltham M, Dobrovic A, Thompson EW.

Clin Exp Metastasis. 2019 Jun 12. doi: 10.1007/s10585-019-09977-y. [Epub ahead of print]

PMID:
31190270
3.

A review of the influence of mammographic density on breast cancer clinical and pathological phenotype.

Shawky MS, Huo CW, Henderson MA, Redfern A, Britt K, Thompson EW.

Breast Cancer Res Treat. 2019 Jun 8. doi: 10.1007/s10549-019-05300-1. [Epub ahead of print] Review.

PMID:
31177342
4.

Quantification of breast tissue density: Correlation between single-sided portable NMR and micro-CT measurements.

Huang X, Ali TS, Nano T, Blick T, Tse BW, Sokolowski K, Tourell MC, Lloyd T, Thompson EW, Momot KI, Hugo HJ.

Magn Reson Imaging. 2019 Jun 6. pii: S0730-725X(19)30082-7. doi: 10.1016/j.mri.2019.06.006. [Epub ahead of print]

PMID:
31176808
5.

Circulating Tumor Cell cluster phenotype allows monitoring response to treatment and predicts survival.

Balakrishnan A, Koppaka D, Anand A, Deb B, Grenci G, Viasnoff V, Thompson EW, Gowda H, Bhat R, Rangarajan A, Thiery JP, Govind Babu K, Kumar P.

Sci Rep. 2019 May 28;9(1):7933. doi: 10.1038/s41598-019-44404-y.

6.

Editorial: Cancer Plasticity and the Microenvironment: Implications for Immunity and Therapy Response.

Behren A, Thompson EW, Anderson RL, Ferrao PT.

Front Oncol. 2019 May 7;9:276. doi: 10.3389/fonc.2019.00276. eCollection 2019. No abstract available.

7.

Hypoxia as a signal for prison breakout in cancer.

Redfern A, Agarwal V, Thompson EW.

Curr Opin Clin Nutr Metab Care. 2019 Jul;22(4):250-263. doi: 10.1097/MCO.0000000000000577.

PMID:
31116106
8.

Transverse relaxation-based assessment of mammographic density and breast tissue composition by single-sided portable NMR.

Ali TS, Tourell MC, Hugo HJ, Pyke C, Yang S, Lloyd T, Thompson EW, Momot KI.

Magn Reson Med. 2019 Sep;82(3):1199-1213. doi: 10.1002/mrm.27781. Epub 2019 Apr 29.

PMID:
31034648
9.

ORAI1 and ORAI3 in Breast Cancer Molecular Subtypes and the Identification of ORAI3 as a Hypoxia Sensitive Gene and a Regulator of Hypoxia Responses.

Azimi I, Milevskiy MJG, Chalmers SB, Yapa KTDS, Robitaille M, Henry C, Baillie GJ, Thompson EW, Roberts-Thomson SJ, Monteith GR.

Cancers (Basel). 2019 Feb 11;11(2). pii: E208. doi: 10.3390/cancers11020208.

10.

The prognostic significance of circulating tumor cells in head and neck and non-small-cell lung cancer.

Kulasinghe A, Kapeleris J, Kimberley R, Mattarollo SR, Thompson EW, Thiery JP, Kenny L, O'Byrne K, Punyadeera C.

Cancer Med. 2018 Dec;7(12):5910-5919. doi: 10.1002/cam4.1832. Epub 2018 Nov 22.

11.

High Coronary Shear Stress in Patients With Coronary Artery Disease Predicts Myocardial Infarction.

Kumar A, Thompson EW, Lefieux A, Molony DS, Davis EL, Chand N, Fournier S, Lee HS, Suh J, Sato K, Ko YA, Molloy D, Chandran K, Hosseini H, Gupta S, Milkas A, Gogas B, Chang HJ, Min JK, Fearon WF, Veneziani A, Giddens DP, King SB 3rd, De Bruyne B, Samady H.

J Am Coll Cardiol. 2018 Oct 16;72(16):1926-1935. doi: 10.1016/j.jacc.2018.07.075.

PMID:
30309470
12.

Low Coronary Wall Shear Stress Is Associated With Severe Endothelial Dysfunction in Patients With Nonobstructive Coronary Artery Disease.

Kumar A, Hung OY, Piccinelli M, Eshtehardi P, Corban MT, Sternheim D, Yang B, Lefieux A, Molony DS, Thompson EW, Zeng W, Bouchi Y, Gupta S, Hosseini H, Raad M, Ko YA, Liu C, McDaniel MC, Gogas BD, Douglas JS, Quyyumi AA, Giddens DP, Veneziani A, Samady H.

JACC Cardiovasc Interv. 2018 Oct 22;11(20):2072-2080. doi: 10.1016/j.jcin.2018.07.004. Epub 2018 Sep 26.

PMID:
30268874
13.

DNA Methylation Profiling of Breast Cancer Cell Lines along the Epithelial Mesenchymal Spectrum-Implications for the Choice of Circulating Tumour DNA Methylation Markers.

Le AV, Szaumkessel M, Tan TZ, Thiery JP, Thompson EW, Dobrovic A.

Int J Mol Sci. 2018 Aug 28;19(9). pii: E2553. doi: 10.3390/ijms19092553.

14.

High mammographic density in women is associated with protumor inflammation.

Huo CW, Hill P, Chew G, Neeson PJ, Halse H, Williams ED, Henderson MA, Thompson EW, Britt KL.

Breast Cancer Res. 2018 Aug 9;20(1):92. doi: 10.1186/s13058-018-1010-2.

15.

The Kraken Wakes: induced EMT as a driver of tumour aggression and poor outcome.

Redfern AD, Spalding LJ, Thompson EW.

Clin Exp Metastasis. 2018 Apr;35(4):285-308. doi: 10.1007/s10585-018-9906-x. Epub 2018 Jun 8. Review.

PMID:
29948647
16.

Intermittent hypoxia induces a metastatic phenotype in breast cancer.

Chen A, Sceneay J, Gödde N, Kinwel T, Ham S, Thompson EW, Humbert PO, Möller A.

Oncogene. 2018 Aug;37(31):4214-4225. doi: 10.1038/s41388-018-0259-3. Epub 2018 May 1.

PMID:
29713057
17.

Transition states that allow cancer to spread.

Thompson EW, Nagaraj SH.

Nature. 2018 Apr;556(7702):442-444. doi: 10.1038/d41586-018-04403-x. No abstract available.

PMID:
29686367
18.

Assessment of CXC ligand 12-mediated calcium signalling and its regulators in basal-like breast cancer cells.

Jamaludin SYN, Azimi I, Davis FM, Peters AA, Gonda TJ, Thompson EW, Roberts-Thomson SJ, Monteith GR.

Oncol Lett. 2018 Apr;15(4):4289-4295. doi: 10.3892/ol.2018.7827. Epub 2018 Jan 19.

19.

InforMD: a new initiative to raise public awareness about breast density.

Hugo HJ, Zysk A, Dasari P, Britt K, Hopper JL, Stone J, Thompson EW, Ingman WV.

Ecancermedicalscience. 2018 Feb 6;12:807. doi: 10.3332/ecancer.2018.807. eCollection 2018.

20.

T1 -based sensing of mammographic density using single-sided portable NMR.

Tourell MC, Ali TS, Hugo HJ, Pyke C, Yang S, Lloyd T, Thompson EW, Momot KI.

Magn Reson Med. 2018 Sep;80(3):1243-1251. doi: 10.1002/mrm.27098. Epub 2018 Feb 4. No abstract available.

PMID:
29399874
21.

Hypoxia-induced reactive oxygen species mediate N-cadherin and SERPINE1 expression, EGFR signalling and motility in MDA-MB-468 breast cancer cells.

Azimi I, Petersen RM, Thompson EW, Roberts-Thomson SJ, Monteith GR.

Sci Rep. 2017 Nov 9;7(1):15140. doi: 10.1038/s41598-017-15474-7.

22.

Targeting epithelial-mesenchymal plasticity in cancer: clinical and preclinical advances in therapy and monitoring.

Bhatia S, Monkman J, Toh AKL, Nagaraj SH, Thompson EW.

Biochem J. 2017 Sep 20;474(19):3269-3306. doi: 10.1042/BCJ20160782. Review.

PMID:
28931648
23.

Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.

Hugo HJ, Gunasinghe NPAD, Hollier BG, Tanaka T, Blick T, Toh A, Hill P, Gilles C, Waltham M, Thompson EW.

Breast Cancer Res. 2017 Jul 27;19(1):86. doi: 10.1186/s13058-017-0880-z.

24.

MicroRNAs in HPV associated cancers: small players with big consequences.

Satapathy S, Batra J, Jeet V, Thompson EW, Punyadeera C.

Expert Rev Mol Diagn. 2017 Jul;17(7):711-722. doi: 10.1080/14737159.2017.1339603. Epub 2017 Jun 15. Review.

PMID:
28597695
25.

TRPC1 is a differential regulator of hypoxia-mediated events and Akt signalling in PTEN-deficient breast cancer cells.

Azimi I, Milevskiy MJG, Kaemmerer E, Turner D, Yapa KTDS, Brown MA, Thompson EW, Roberts-Thomson SJ, Monteith GR.

J Cell Sci. 2017 Jul 15;130(14):2292-2305. doi: 10.1242/jcs.196659. Epub 2017 May 30.

26.

Epithelial-mesenchymal plasticity and circulating tumor cells: Travel companions to metastases.

Francart ME, Lambert J, Vanwynsberghe AM, Thompson EW, Bourcy M, Polette M, Gilles C.

Dev Dyn. 2018 Mar;247(3):432-450. doi: 10.1002/dvdy.24506. Epub 2017 May 26. Review.

27.

A fence barrier method of leading edge cell capture for explorative biochemical research.

Wager LJ, Murray RZ, Thompson EW, Leavesley DI.

Cell Adh Migr. 2017 Sep 3;11(5-6):496-503. doi: 10.1080/19336918.2016.1269997. Epub 2017 Feb 17.

28.

Erratum: An optimised direct lysis method for gene expression studies on low cell numbers.

Le AV, Huang D, Blick T, Thompson EW, Dobrovic A.

Sci Rep. 2017 Mar 9;7:43075. doi: 10.1038/srep43075. No abstract available.

29.

Return of EMT to the Land Downunder: TEMTIA-VII, Melbourne, 2015.

Newgreen DF, Thompson EW.

Cells Tissues Organs. 2017;203(2):69-70. doi: 10.1159/000454686. Epub 2017 Feb 20. No abstract available.

30.

Enrichment of circulating head and neck tumour cells using spiral microfluidic technology.

Kulasinghe A, Tran TH, Blick T, O'Byrne K, Thompson EW, Warkiani ME, Nelson C, Kenny L, Punyadeera C.

Sci Rep. 2017 Feb 15;7:42517. doi: 10.1038/srep42517.

31.

A Transcriptional Program for Detecting TGFβ-Induced EMT in Cancer.

Foroutan M, Cursons J, Hediyeh-Zadeh S, Thompson EW, Davis MJ.

Mol Cancer Res. 2017 May;15(5):619-631. doi: 10.1158/1541-7786.MCR-16-0313. Epub 2017 Jan 23. Erratum in: Mol Cancer Res. 2017 Dec;15(12 ):1803.

32.

CCL2-driven inflammation increases mammary gland stromal density and cancer susceptibility in a transgenic mouse model.

Sun X, Glynn DJ, Hodson LJ, Huo C, Britt K, Thompson EW, Woolford L, Evdokiou A, Pollard JW, Robertson SA, Ingman WV.

Breast Cancer Res. 2017 Jan 11;19(1):4. doi: 10.1186/s13058-016-0796-z.

33.

Mammographic density: a potential monitoring biomarker for adjuvant and preventative breast cancer endocrine therapies.

Shawky MS, Martin H, Hugo HJ, Lloyd T, Britt KL, Redfern A, Thompson EW.

Oncotarget. 2017 Jan 17;8(3):5578-5591. doi: 10.18632/oncotarget.13484. Review.

34.

Genome-wide gain-of-function screen for genes that induce epithelial-to-mesenchymal transition in breast cancer.

Škalamera D, Dahmer-Heath M, Stevenson AJ, Pinto C, Shah ET, Daignault SM, Said NA, Davis M, Haass NK, Williams ED, Hollier BG, Thompson EW, Gabrielli B, Gonda TJ.

Oncotarget. 2016 Sep 20;7(38):61000-61020. doi: 10.18632/oncotarget.11314.

35.

Mammographically dense human breast tissue stimulates MCF10DCIS.com progression to invasive lesions and metastasis.

Huo CW, Waltham M, Khoo C, Fox SB, Hill P, Chen S, Chew GL, Price JT, Nguyen CH, Williams ED, Henderson M, Thompson EW, Britt KL.

Breast Cancer Res. 2016 Oct 25;18(1):106.

36.

Human glandular organoid formation in murine engineering chambers after collagenase digestion and flow cytometry isolation of normal human breast tissue single cells.

Huo CW, Huang D, Chew GL, Hill P, Vohora A, Ingman WV, Glynn DJ, Godde N, Henderson MA, Thompson EW, Britt KL.

Cell Biol Int. 2016 Nov;40(11):1212-1223. doi: 10.1002/cbin.10675. Epub 2016 Sep 13.

PMID:
27590622
37.

Short term ex-vivo expansion of circulating head and neck tumour cells.

Kulasinghe A, Perry C, Warkiani ME, Blick T, Davies A, O'Byrne K, Thompson EW, Nelson CC, Vela I, Punyadeera C.

Oncotarget. 2016 Sep 13;7(37):60101-60109. doi: 10.18632/oncotarget.11159.

38.

Differential effects of two-pore channel protein 1 and 2 silencing in MDA-MB-468 breast cancer cells.

Jahidin AH, Stewart TA, Thompson EW, Roberts-Thomson SJ, Monteith GR.

Biochem Biophys Res Commun. 2016 Sep 2;477(4):731-736. doi: 10.1016/j.bbrc.2016.06.127. Epub 2016 Jun 25.

PMID:
27353380
39.

Tissue Factor Induced by Epithelial-Mesenchymal Transition Triggers a Procoagulant State That Drives Metastasis of Circulating Tumor Cells.

Bourcy M, Suarez-Carmona M, Lambert J, Francart ME, Schroeder H, Delierneux C, Skrypek N, Thompson EW, Jérusalem G, Berx G, Thiry M, Blacher S, Hollier BG, Noël A, Oury C, Polette M, Gilles C.

Cancer Res. 2016 Jul 15;76(14):4270-82. doi: 10.1158/0008-5472.CAN-15-2263. Epub 2016 May 24.

40.

Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells.

Tachtsidis A, McInnes LM, Jacobsen N, Thompson EW, Saunders CM.

Clin Exp Metastasis. 2016 Aug;33(6):521-50. doi: 10.1007/s10585-016-9796-8. Epub 2016 May 17. Review.

41.

Janus kinases and Src family kinases in the regulation of EGF-induced vimentin expression in MDA-MB-468 breast cancer cells.

Stewart TA, Azimi I, Brooks AJ, Thompson EW, Roberts-Thomson SJ, Monteith GR.

Int J Biochem Cell Biol. 2016 Jul;76:64-74. doi: 10.1016/j.biocel.2016.05.007. Epub 2016 May 7.

PMID:
27163529
42.

Exemplary multiplex bisulfite amplicon data used to demonstrate the utility of Methpat.

Wong NC, Pope BJ, Candiloro I, Korbie D, Trau M, Wong SQ, Mikeska T, van Denderen BJ, Thompson EW, Eggers S, Doyle SR, Dobrovic A.

Gigascience. 2015 Nov 26;4:55. doi: 10.1186/s13742-015-0098-x. eCollection 2015.

43.

Heterogeneity of miR-10b expression in circulating tumor cells.

Gasch C, Plummer PN, Jovanovic L, McInnes LM, Wescott D, Saunders CM, Schneeweiss A, Wallwiener M, Nelson C, Spring KJ, Riethdorf S, Thompson EW, Pantel K, Mellick AS.

Sci Rep. 2015 Nov 2;5:15980. doi: 10.1038/srep15980.

44.

An epithelial to mesenchymal transition programme does not usually drive the phenotype of invasive lobular carcinomas.

McCart Reed AE, Kutasovic JR, Vargas AC, Jayanthan J, Al-Murrani A, Reid LE, Chambers R, Da Silva L, Melville L, Evans E, Porter A, Papadimos D, Thompson EW, Lakhani SR, Simpson PT.

J Pathol. 2016 Mar;238(4):489-94. doi: 10.1002/path.4668. Epub 2016 Feb 1.

PMID:
26510554
45.

Proteoglycans: Potential Agents in Mammographic Density and the Associated Breast Cancer Risk.

Shawky MS, Ricciardelli C, Lord M, Whitelock J, Ferro V, Britt K, Thompson EW.

J Mammary Gland Biol Neoplasia. 2015 Dec;20(3-4):121-31. Review.

PMID:
26501889
46.

Altered purinergic receptor-Ca²⁺ signaling associated with hypoxia-induced epithelial-mesenchymal transition in breast cancer cells.

Azimi I, Beilby H, Davis FM, Marcial DL, Kenny PA, Thompson EW, Roberts-Thomson SJ, Monteith GR.

Mol Oncol. 2016 Jan;10(1):166-78. doi: 10.1016/j.molonc.2015.09.006. Epub 2015 Sep 25.

47.

Editorial: Cellular and Phenotypic Plasticity in Cancer.

Ferrao PT, Behren A, Anderson RL, Thompson EW.

Front Oncol. 2015 Aug 4;5:171. doi: 10.3389/fonc.2015.00171. eCollection 2015. No abstract available.

48.

An optimised direct lysis method for gene expression studies on low cell numbers.

Le AV, Huang D, Blick T, Thompson EW, Dobrovic A.

Sci Rep. 2015 Aug 5;5:12859. doi: 10.1038/srep12859. Erratum in: Sci Rep. 2017 Mar 09;7:43075.

49.

Increased COX-2 expression in epithelial and stromal cells of high mammographic density tissues and in a xenograft model of mammographic density.

Chew GL, Huo CW, Huang D, Hill P, Cawson J, Frazer H, Hopper JL, Haviv I, Henderson MA, Britt K, Thompson EW.

Breast Cancer Res Treat. 2015 Aug;153(1):89-99. doi: 10.1007/s10549-015-3520-2. Epub 2015 Jul 31.

PMID:
26227474
50.

New Insights on COX-2 in Chronic Inflammation Driving Breast Cancer Growth and Metastasis.

Hugo HJ, Saunders C, Ramsay RG, Thompson EW.

J Mammary Gland Biol Neoplasia. 2015 Dec;20(3-4):109-19. doi: 10.1007/s10911-015-9333-4. Epub 2015 Jul 21. Review.

PMID:
26193871

Supplemental Content

Loading ...
Support Center